0001618835-17-000002.txt : 20170306 0001618835-17-000002.hdr.sgml : 20170306 20170306155534 ACCESSION NUMBER: 0001618835-17-000002 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20170302 FILED AS OF DATE: 20170306 DATE AS OF CHANGE: 20170306 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Neothetics, Inc. CENTRAL INDEX KEY: 0001618835 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 208527075 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 9171 TOWNE CENTRE DRIVE, SUITE 270 CITY: SAN DIEGO STATE: CA ZIP: 92122 BUSINESS PHONE: (858) 750-1008 MAIL ADDRESS: STREET 1: 9171 TOWNE CENTRE DRIVE, SUITE 270 CITY: SAN DIEGO STATE: CA ZIP: 92122 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Feldman Maria CENTRAL INDEX KEY: 0001674083 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-36754 FILM NUMBER: 17667807 MAIL ADDRESS: STREET 1: 9171 TOWNE CENTRE DRIVE, SUITE 270 CITY: SAN DIEGO STATE: CA ZIP: 92122 4 1 primary_doc.xml PRIMARY DOCUMENT X0306 4 2017-03-02 0 0001618835 Neothetics, Inc. NEOT 0001674083 Feldman Maria 9171 TOWNE CENTRE DRIVE, SUITE 250 SAN DIEGO CA 92122 0 1 0 0 VP Clinical Research & Operati Stock Option (Right to Buy) 1.43 2017-03-02 4 A 0 90000 0 A 2027-03-02 Common Stock 90000 90000 D (i) One half of the option shares vest upon receipt and completed analysis of LIPO-202 CL-31 trial data and (ii) the remaining one half of the option shares vest at the earlier of (a) 12/31/2017 or (b) upon the event of a change in control. /s/ Maria Feldman 2017-03-06